Longevity Health Holdings Inc (XAGE)
Longevity Health Holdings Inc. is a healthcare company focused on bio-aesthetics, with activities centered on the development, manufacturing, and marketing of cosmetic skincare and haircare products. Its product work includes Carmell Secretome and Elevai Exosomes, which are designed to support skin and hair health through ingredients such as growth factors, proteins, peptides, cytokines, and other small molecules associated with the body’s natural healing processes. The company also develops a microemulsion formulation intended to deliver both lipophilic and hydrophilic ingredients without using a group of 14 excipients commonly found in cosmetic products. In addition, Longevity Health Holdings has a licensing agreement with Carnegie Mellon University to develop and commercialize biocompatible plasma-based plastics. Formerly known as Carmell Corporation, the company adopted its current name in March 2025 and is headquartered in Pittsburgh, Pennsylvania. It was founded in 2008 and trades as common stock on OTC Markets under the symbol XAGE.
Jump directly to the stock analysis sections supported by the latest available data.
| Ticker | Fair Value | Fair Value Upside/Downside | Fair Value Rating | Analyst Price Target | Analyst Target Upside/Downside | Overall Financial Health | Dividend Yield | Next Earnings Date | Price-to-Sales Ratio | Market Cap | Enterprise Value | Total Debt / Total Capital | Free Float / Shares Outstanding | Altman Z-Score | Free Cash Flow / Net Income |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
OTC-XAGE
|
$0.24
|
39.8% Upside
|
Undervalued
|
Not available
|
Not available
|
Weak
|
0.0%
|
November 13, 2026
|
0.2x
|
420.804 K
|
707.278 K
|
43.3%
|
67.3%
|
-134.0
|
36.1%
|
